| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 1.91e-04 | 120 | 19 | 3 | GO:0004222 | |
| GeneOntologyMolecularFunction | ATPase activator activity | 4.18e-04 | 32 | 19 | 2 | GO:0001671 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 8.52e-04 | 200 | 19 | 3 | GO:0008237 | |
| GeneOntologyMolecularFunction | ATPase regulator activity | 1.19e-03 | 54 | 19 | 2 | GO:0060590 | |
| GeneOntologyMolecularFunction | Hsp70 protein binding | 1.62e-03 | 63 | 19 | 2 | GO:0030544 | |
| GeneOntologyMolecularFunction | cadherin binding | 3.84e-03 | 339 | 19 | 3 | GO:0045296 | |
| GeneOntologyMolecularFunction | unfolded protein binding | 6.30e-03 | 126 | 19 | 2 | GO:0051082 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 7.44e-03 | 430 | 19 | 3 | GO:0004175 | |
| GeneOntologyBiologicalProcess | collagen catabolic process | 1.51e-05 | 53 | 19 | 3 | GO:0030574 | |
| GeneOntologyBiologicalProcess | chorio-allantoic fusion | 3.60e-05 | 10 | 19 | 2 | GO:0060710 | |
| GeneOntologyBiologicalProcess | labyrinthine layer morphogenesis | 3.00e-04 | 28 | 19 | 2 | GO:0060713 | |
| GeneOntologyBiologicalProcess | collagen metabolic process | 3.22e-04 | 148 | 19 | 3 | GO:0032963 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 3.43e-04 | 377 | 19 | 4 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 3.46e-04 | 378 | 19 | 4 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 3.49e-04 | 379 | 19 | 4 | GO:0045229 | |
| GeneOntologyBiologicalProcess | embryonic placenta morphogenesis | 4.17e-04 | 33 | 19 | 2 | GO:0060669 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in embryonic placenta development | 4.43e-04 | 34 | 19 | 2 | GO:0060706 | |
| GeneOntologyBiologicalProcess | response to temperature stimulus | 8.69e-04 | 208 | 19 | 3 | GO:0009266 | |
| GeneOntologyCellularComponent | ciliary pocket membrane | 2.35e-06 | 3 | 19 | 2 | GO:0020018 | |
| GeneOntologyCellularComponent | ciliary pocket | 2.35e-06 | 3 | 19 | 2 | GO:0020016 | |
| GeneOntologyCellularComponent | extracellular matrix | 2.42e-04 | 656 | 19 | 5 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 2.45e-04 | 658 | 19 | 5 | GO:0030312 | |
| GeneOntologyCellularComponent | nuclear inner membrane | 1.30e-03 | 59 | 19 | 2 | GO:0005637 | |
| Domain | Hemopexin_CS | 6.01e-07 | 17 | 19 | 3 | IPR018486 | |
| Domain | Pept_M10A_stromelysin-type | 7.21e-07 | 18 | 19 | 3 | IPR016293 | |
| Domain | EHD1/EHD3 | 9.80e-07 | 2 | 19 | 2 | IPR029951 | |
| Domain | Peptidoglycan-bd-like | 1.01e-06 | 20 | 19 | 3 | IPR002477 | |
| Domain | PG_binding_1 | 1.01e-06 | 20 | 19 | 3 | PF01471 | |
| Domain | HEMOPEXIN | 1.56e-06 | 23 | 19 | 3 | PS00024 | |
| Domain | - | 1.56e-06 | 23 | 19 | 3 | 2.110.10.10 | |
| Domain | Hemopexin-like_dom | 1.56e-06 | 23 | 19 | 3 | IPR000585 | |
| Domain | HEMOPEXIN_2 | 1.56e-06 | 23 | 19 | 3 | PS51642 | |
| Domain | Hemopexin-like_repeat | 1.56e-06 | 23 | 19 | 3 | IPR018487 | |
| Domain | Hemopexin | 1.56e-06 | 23 | 19 | 3 | PF00045 | |
| Domain | HX | 1.56e-06 | 23 | 19 | 3 | SM00120 | |
| Domain | Pept_M10A | 1.56e-06 | 23 | 19 | 3 | IPR021190 | |
| Domain | M10A_MMP | 1.56e-06 | 23 | 19 | 3 | IPR033739 | |
| Domain | Peptidase_M10 | 1.78e-06 | 24 | 19 | 3 | PF00413 | |
| Domain | ZnMc | 3.21e-06 | 29 | 19 | 3 | SM00235 | |
| Domain | Peptidase_Metallo | 3.21e-06 | 29 | 19 | 3 | IPR006026 | |
| Domain | DUF3377 | 5.88e-06 | 4 | 19 | 2 | PF11857 | |
| Domain | Pept_M10A_metallopeptidase_C | 5.88e-06 | 4 | 19 | 2 | IPR021805 | |
| Domain | CYSTEINE_SWITCH | 9.28e-06 | 41 | 19 | 3 | PS00546 | |
| Domain | EHD_N | 9.79e-06 | 5 | 19 | 2 | PF16880 | |
| Domain | EHD_N | 9.79e-06 | 5 | 19 | 2 | IPR031692 | |
| Domain | Pept_M10_metallopeptidase | 1.07e-05 | 43 | 19 | 3 | IPR001818 | |
| Domain | EF-hand_4 | 4.39e-05 | 10 | 19 | 2 | PF12763 | |
| Domain | EH | 5.36e-05 | 11 | 19 | 2 | PS50031 | |
| Domain | EH | 5.36e-05 | 11 | 19 | 2 | SM00027 | |
| Domain | EH_dom | 5.36e-05 | 11 | 19 | 2 | IPR000261 | |
| Domain | - | 7.24e-05 | 81 | 19 | 3 | 3.40.390.10 | |
| Domain | MetalloPept_cat_dom | 7.24e-05 | 81 | 19 | 3 | IPR024079 | |
| Domain | G_DYNAMIN_dom | 8.86e-05 | 14 | 19 | 2 | IPR030381 | |
| Domain | G_DYNAMIN_2 | 8.86e-05 | 14 | 19 | 2 | PS51718 | |
| Domain | Dynamin_N | 1.02e-04 | 15 | 19 | 2 | PF00350 | |
| Domain | Dynamin_SF | 1.02e-04 | 15 | 19 | 2 | IPR022812 | |
| Domain | Pept_M10A_Zn_BS | 1.02e-04 | 15 | 19 | 2 | IPR021158 | |
| Domain | Dynamin_GTPase | 1.02e-04 | 15 | 19 | 2 | IPR001401 | |
| Domain | ZINC_PROTEASE | 1.28e-04 | 98 | 19 | 3 | PS00142 | |
| Domain | DnaJ_domain_CS | 3.39e-04 | 27 | 19 | 2 | IPR018253 | |
| Domain | DnaJ | 1.08e-03 | 48 | 19 | 2 | PF00226 | |
| Domain | DnaJ | 1.12e-03 | 49 | 19 | 2 | SM00271 | |
| Domain | DNAJ_1 | 1.12e-03 | 49 | 19 | 2 | PS00636 | |
| Domain | DNAJ_2 | 1.12e-03 | 49 | 19 | 2 | PS50076 | |
| Domain | - | 1.12e-03 | 49 | 19 | 2 | 1.10.287.110 | |
| Domain | DnaJ_domain | 1.21e-03 | 51 | 19 | 2 | IPR001623 | |
| Domain | RRM | 1.31e-03 | 217 | 19 | 3 | SM00360 | |
| Domain | RRM_dom | 1.49e-03 | 227 | 19 | 3 | IPR000504 | |
| Domain | RRM | 1.54e-03 | 230 | 19 | 3 | PS50102 | |
| Domain | - | 1.83e-03 | 244 | 19 | 3 | 3.30.70.330 | |
| Domain | Nucleotide-bd_a/b_plait | 2.14e-03 | 258 | 19 | 3 | IPR012677 | |
| Domain | EF-hand_1 | 1.03e-02 | 152 | 19 | 2 | PF00036 | |
| Domain | EF_Hand_1_Ca_BS | 1.34e-02 | 175 | 19 | 2 | IPR018247 | |
| Domain | EF_HAND_1 | 1.80e-02 | 204 | 19 | 2 | PS00018 | |
| Domain | EF_HAND_2 | 2.27e-02 | 231 | 19 | 2 | PS50222 | |
| Domain | EF_hand_dom | 2.29e-02 | 232 | 19 | 2 | IPR002048 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 5.22e-06 | 29 | 17 | 3 | MM15981 | |
| Pathway | WP_MATRIX_METALLOPROTEINASES | 5.80e-06 | 30 | 17 | 3 | M39652 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.90e-06 | 114 | 17 | 4 | MM14571 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.01e-05 | 140 | 17 | 4 | M587 | |
| Pathway | WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION | 2.14e-05 | 46 | 17 | 3 | M46450 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.16e-04 | 258 | 17 | 4 | MM14572 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 3.84e-04 | 300 | 17 | 4 | M610 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 7.07e-04 | 33 | 17 | 2 | M26976 | |
| Pathway | REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES | 9.38e-04 | 38 | 17 | 2 | MM14611 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 9.45e-04 | 381 | 17 | 4 | M48063 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.82e-03 | 53 | 17 | 2 | MM14566 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.64e-03 | 64 | 17 | 2 | M26953 | |
| Pubmed | 7.71e-08 | 16 | 19 | 3 | 10949577 | ||
| Pubmed | 2.11e-07 | 22 | 19 | 3 | 10419448 | ||
| Pubmed | Functional interactions between matrix metalloproteinases and glycosaminoglycans. | 2.11e-07 | 22 | 19 | 3 | 23421805 | |
| Pubmed | 2.78e-07 | 24 | 19 | 3 | 15734845 | ||
| Pubmed | Zic2 promotes tumor growth and metastasis via PAK4 in hepatocellular carcinoma. | 2.83e-07 | 2 | 19 | 2 | 28577975 | |
| Pubmed | SUMOylation of EHD3 Modulates Tubulation of the Endocytic Recycling Compartment. | 2.83e-07 | 2 | 19 | 2 | 26226295 | |
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 24019528 | ||
| Pubmed | 8.48e-07 | 3 | 19 | 2 | 12121420 | ||
| Pubmed | Early steps in primary cilium assembly require EHD1/EHD3-dependent ciliary vesicle formation. | 8.48e-07 | 3 | 19 | 2 | 25686250 | |
| Pubmed | 9.76e-07 | 36 | 19 | 3 | 20587546 | ||
| Pubmed | Rabenosyn-5 and EHD1 interact and sequentially regulate protein recycling to the plasma membrane. | 1.70e-06 | 4 | 19 | 2 | 15020713 | |
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 17233914 | ||
| Pubmed | Interactions between EHD proteins and Rab11-FIP2: a role for EHD3 in early endosomal transport. | 1.70e-06 | 4 | 19 | 2 | 16251358 | |
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 10673336 | ||
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 35062057 | ||
| Pubmed | C-terminal EH-domain-containing proteins: consensus for a role in endocytic trafficking, EH? | 1.70e-06 | 4 | 19 | 2 | 16155252 | |
| Pubmed | Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function. | 1.70e-06 | 4 | 19 | 2 | 29212907 | |
| Pubmed | 1.70e-06 | 4 | 19 | 2 | 27189942 | ||
| Pubmed | EH domain proteins regulate cardiac membrane protein targeting. | 2.82e-06 | 5 | 19 | 2 | 20489164 | |
| Pubmed | 2.82e-06 | 5 | 19 | 2 | 12661033 | ||
| Pubmed | MT3-MMP Promotes Excitatory Synapse Formation by Promoting Nogo-66 Receptor Ectodomain Shedding. | 2.82e-06 | 5 | 19 | 2 | 29196321 | |
| Pubmed | MICAL-L1 links EHD1 to tubular recycling endosomes and regulates receptor recycling. | 4.24e-06 | 6 | 19 | 2 | 19864458 | |
| Pubmed | Membrane-type matrix metalloproteinases: Their functions and regulations. | 5.93e-06 | 7 | 19 | 2 | 25794647 | |
| Pubmed | Cleavage of metastasis suppressor gene product KiSS-1 protein/metastin by matrix metalloproteinases. | 5.93e-06 | 7 | 19 | 2 | 12879005 | |
| Pubmed | Myosin Vb interacts with Rab8a on a tubular network containing EHD1 and EHD3. | 7.90e-06 | 8 | 19 | 2 | 17507647 | |
| Pubmed | Association of insulin-like growth factor 1 receptor with EHD1 and SNAP29. | 1.02e-05 | 9 | 19 | 2 | 11423532 | |
| Pubmed | The endocytic recycling regulatory protein EHD1 Is required for ocular lens development. | 1.55e-05 | 11 | 19 | 2 | 26455409 | |
| Pubmed | 1.55e-05 | 11 | 19 | 2 | 10949161 | ||
| Pubmed | 3.38e-05 | 16 | 19 | 2 | 37701782 | ||
| Pubmed | 3.73e-05 | 120 | 19 | 3 | 27320910 | ||
| Pubmed | PAK4 promotes kinase-independent stabilization of RhoU to modulate cell adhesion. | 4.73e-05 | 130 | 19 | 3 | 26598620 | |
| Pubmed | 6.49e-05 | 22 | 19 | 2 | 11147971 | ||
| Pubmed | The diverse members of the mammalian HSP70 machine show distinct chaperone-like activities. | 7.10e-05 | 23 | 19 | 2 | 21231916 | |
| Pubmed | 8.14e-05 | 156 | 19 | 3 | 32850835 | ||
| Pubmed | 8.42e-05 | 25 | 19 | 2 | 27483141 | ||
| Pubmed | 1.03e-04 | 463 | 19 | 4 | 27503909 | ||
| Pubmed | 1.06e-04 | 28 | 19 | 2 | 26884322 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 1.24e-04 | 180 | 19 | 3 | 35198878 | |
| Pubmed | 1.29e-04 | 491 | 19 | 4 | 36273042 | ||
| Pubmed | Cdc37 interacts with the glycine-rich loop of Hsp90 client kinases. | 1.57e-04 | 34 | 19 | 2 | 16611982 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 1.92e-04 | 1038 | 19 | 5 | 26673895 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 2.10e-04 | 558 | 19 | 4 | 27591049 | |
| Pubmed | 2.69e-04 | 1116 | 19 | 5 | 31753913 | ||
| Pubmed | 2.88e-04 | 46 | 19 | 2 | 21102462 | ||
| Pubmed | 3.49e-04 | 638 | 19 | 4 | 33239621 | ||
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | 3.68e-04 | 647 | 19 | 4 | 26618866 | |
| Pubmed | 3.86e-04 | 655 | 19 | 4 | 35819319 | ||
| Pubmed | 4.74e-04 | 284 | 19 | 3 | 29459677 | ||
| Pubmed | 5.17e-04 | 708 | 19 | 4 | 39231216 | ||
| Interaction | MMP16 interactions | 5.75e-07 | 18 | 19 | 3 | int:MMP16 | |
| Interaction | SCP2D1 interactions | 2.52e-06 | 3 | 19 | 2 | int:SCP2D1 | |
| Interaction | MMP1 interactions | 5.41e-06 | 37 | 19 | 3 | int:MMP1 | |
| Interaction | EHD1 interactions | 1.25e-05 | 157 | 19 | 4 | int:EHD1 | |
| Interaction | RBSN interactions | 2.99e-05 | 65 | 19 | 3 | int:RBSN | |
| Interaction | EHD2 interactions | 3.58e-05 | 69 | 19 | 3 | int:EHD2 | |
| Interaction | MMP20 interactions | 3.77e-05 | 10 | 19 | 2 | int:MMP20 | |
| Interaction | MMP17 interactions | 3.77e-05 | 10 | 19 | 2 | int:MMP17 | |
| Interaction | MMP27 interactions | 4.61e-05 | 11 | 19 | 2 | int:MMP27 | |
| Interaction | MMP12 interactions | 4.61e-05 | 11 | 19 | 2 | int:MMP12 | |
| Interaction | MMP11 interactions | 5.53e-05 | 12 | 19 | 2 | int:MMP11 | |
| Interaction | RAB11FIP2 interactions | 6.22e-05 | 83 | 19 | 3 | int:RAB11FIP2 | |
| Interaction | KISS1 interactions | 1.14e-04 | 17 | 19 | 2 | int:KISS1 | |
| Interaction | MMP24 interactions | 1.43e-04 | 19 | 19 | 2 | int:MMP24 | |
| Interaction | NEK9 interactions | 1.48e-04 | 111 | 19 | 3 | int:NEK9 | |
| Interaction | EHD4 interactions | 2.25e-04 | 128 | 19 | 3 | int:EHD4 | |
| Interaction | MMP8 interactions | 2.49e-04 | 25 | 19 | 2 | int:MMP8 | |
| Interaction | MMP10 interactions | 3.61e-04 | 30 | 19 | 2 | int:MMP10 | |
| Interaction | MMP13 interactions | 3.85e-04 | 31 | 19 | 2 | int:MMP13 | |
| Interaction | EHD3 interactions | 4.11e-04 | 32 | 19 | 2 | int:EHD3 | |
| Interaction | OXSM interactions | 4.92e-04 | 35 | 19 | 2 | int:OXSM | |
| Interaction | SNW1 interactions | 5.20e-04 | 747 | 19 | 5 | int:SNW1 | |
| Interaction | CIAO2A interactions | 5.44e-04 | 173 | 19 | 3 | int:CIAO2A | |
| Cytoband | 7q36.3 | 4.45e-05 | 24 | 19 | 2 | 7q36.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q36 | 1.96e-03 | 159 | 19 | 2 | chr7q36 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.24e-02 | 1192 | 19 | 3 | chr19q13 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 9.25e-07 | 24 | 15 | 3 | 891 | |
| GeneFamily | RNA binding motif containing | 6.61e-04 | 213 | 15 | 3 | 725 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 7.39e-04 | 49 | 15 | 2 | 584 | |
| GeneFamily | EF-hand domain containing | 1.38e-02 | 219 | 15 | 2 | 863 | |
| ToppCell | BAL-Mild-cDC_4|Mild / Compartment, Disease Groups and Clusters | 5.73e-05 | 179 | 19 | 3 | 68511e87b12b8253de7771e5ccfc5869248b8450 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.62e-05 | 188 | 19 | 3 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.83e-05 | 190 | 19 | 3 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.61e-05 | 197 | 19 | 3 | e6cbfa267eb2e05b441fd034786faae07bb0e081 | |
| ToppCell | 356C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.61e-05 | 197 | 19 | 3 | 69d5b8588046d119b5dff9a7fd6f49e97e00a5b7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-Stress_sig-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.84e-05 | 199 | 19 | 3 | 26bb93347e6722abd174dfa62cab692ce2b7eb23 | |
| Drug | MMI270 | 3.99e-07 | 18 | 19 | 3 | CID000446504 | |
| Drug | DA-125 | 1.27e-06 | 26 | 19 | 3 | CID000114758 | |
| Drug | mercuric acetate | 1.97e-06 | 30 | 19 | 3 | CID000015337 | |
| Drug | Batimastat | 1.98e-06 | 3 | 19 | 2 | DB03880 | |
| Drug | malolactomycin D | 2.41e-06 | 32 | 19 | 3 | CID006449115 | |
| Drug | latanoprost acid | 4.77e-06 | 40 | 19 | 3 | CID006441636 | |
| Drug | AC1L9M3B | 1.72e-05 | 61 | 19 | 3 | CID000448562 | |
| Drug | 4-aminophenyl | 1.81e-05 | 62 | 19 | 3 | CID000181201 | |
| Drug | Marimastat | 1.84e-05 | 8 | 19 | 2 | DB00786 | |
| Drug | diacerein | 1.90e-05 | 63 | 19 | 3 | CID000026248 | |
| Drug | AC1L1GXT | 3.08e-05 | 74 | 19 | 3 | CID000003890 | |
| Drug | A0395 | 3.20e-05 | 75 | 19 | 3 | CID009906466 | |
| Drug | AC1NSU5S | 3.20e-05 | 75 | 19 | 3 | CID005316299 | |
| Drug | 1,10-phenanthroline | 6.24e-05 | 267 | 19 | 4 | CID000001318 | |
| Drug | pirfenidone | 1.97e-04 | 138 | 19 | 3 | CID000040632 | |
| Drug | Pro-leu-gly | 2.12e-04 | 26 | 19 | 2 | CID000169533 | |
| Disease | clear cell renal cell carcinoma (is_marker_for) | 2.05e-04 | 33 | 19 | 2 | DOID:4467 (is_marker_for) | |
| Disease | biological sex | 9.48e-03 | 230 | 19 | 2 | PATO_0000047 | |
| Disease | Cleft palate, cleft lip | 1.37e-02 | 279 | 19 | 2 | EFO_0003959, HP_0000175 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GGGPSGSGGGSHFSF | 291 | P50548 | |
| SGGGGESDGFFHPEG | 991 | Q96EV2 | |
| GPGSGIGGDAHFDED | 186 | P39900 | |
| SGFHGDSSPFDGEGG | 226 | Q9Y5R2 | |
| GGSFAGSFGGAGGHA | 631 | P52272 | |
| GPLGDSLGGDHFAGG | 21 | Q0D2I5 | |
| GGGFGPADDHGYGVS | 706 | Q8TCG5 | |
| EGSGGGGGMDDIFSH | 76 | O60884 | |
| EGLNGGGGGGSHFDS | 71 | O75190 | |
| GGGGGSHFDSPFEFG | 76 | O75190 | |
| RGEEEEGGGGFPHFG | 116 | A6NHQ4 | |
| FSGPKGGHGDDGIDG | 1456 | A8TX70 | |
| YGGSPDHKHGGGSGG | 366 | Q96PX6 | |
| PFGHGYGEGAGEGID | 421 | Q9H4M9 | |
| GRFAGHSEAGGGSGD | 136 | O96013 | |
| RGGEGPGHDFRGGDF | 86 | P78332 | |
| GGAFEGTLHGPFGHG | 411 | Q9NZN3 | |
| PFGHGYGEGAGEGID | 421 | Q9NZN3 | |
| GFHGDSSPFDGEGGF | 191 | P51512 | |
| SPAHGGGGGGSRFEF | 26 | Q8IY26 | |
| FGDSAPGGGQHGLFG | 126 | O95409 |